No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols* / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
-
Cyclophosphamide / adverse effects
-
Cyclophosphamide / therapeutic use
-
Humans
-
Leukemia, Lymphocytic, Chronic, B-Cell* / blood
-
Leukemia, Lymphocytic, Chronic, B-Cell* / diagnosis
-
Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
-
Leukemia, Lymphocytic, Chronic, B-Cell* / pathology
-
Neoplasm, Residual* / blood
-
Neoplasm, Residual* / diagnosis
-
Randomized Controlled Trials as Topic
-
Rituximab / adverse effects
-
Rituximab / therapeutic use
-
Survival Analysis
Substances
-
ibrutinib
-
venetoclax
-
fludarabine
-
Cyclophosphamide
-
Rituximab